Therapeutically Targeting Skeletal Muscle to Treat Type II Diabetes: Could Urocortin 2 be Exercise in a Bottle?

Feb 1, 2021 5:25pm ‐ Feb 1, 2021 5:50pm

Fat Accumulation in Muscle: Implications for Diabetes

Feb 1, 2021 5:50pm ‐ Feb 1, 2021 6:15pm

Coffee Break

Feb 1, 2021 6:15pm ‐ Feb 1, 2021 6:40am

Short Talk: Contraction Response in Skeletal Muscle Glucose Uptake Is Regulated by the Two RabGAPs TBC1D1, TBC1D4 and the Key Components of Exercise Signaling, AMPK and Rac1, in a Cooperative Manner

Feb 1, 2021 6:40pm ‐ Feb 1, 2021 6:55pm

Short Talk: Systemic Benefits of Gc Inhibition to Preserve Insulin Sensitivity

Feb 1, 2021 6:55pm ‐ Feb 1, 2021 7:10pm

Short Talk: Canonical and Non-Canonical Clock Regulators in Obesity and Diabetes

Feb 1, 2021 7:10pm ‐ Feb 1, 2021 7:25pm

Short Talk: An Endocrine-Hepato-Muscular Metabolic Cycle Links Skeletal Muscle Atrophy and Hyperglycemia in Type 2 Diabetes

Feb 1, 2021 7:25pm ‐ Feb 1, 2021 7:40pm

Short Talk: GDF15 as a Regulator of Energy Metabolism: Physiology vs. Pharmacology

Feb 1, 2021 7:40pm ‐ Feb 1, 2021 7:55pm

Obesity Metabolic Phenotypes Leading to Type 2 Diabetes Mellitus: Implications for Personalized Prevention

Feb 2, 2021 10:00am ‐ Feb 2, 2021 10:25am

Diabetes – One Name, Many Variations

Feb 2, 2021 10:00am ‐ Feb 2, 2021 1:00pm